Gland Pharma Statistics

Total Valuation

Gland Pharma has a market cap or net worth of INR 293.17 billion. The enterprise value is 268.23 billion.

Market Cap	293.17B
Enterprise Value	268.23B

Important Dates

The next estimated earnings date is Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	Aug 16, 2024

Share Statistics

Gland Pharma has 164.75 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	164.75M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	36.10%
Float	73.17M

Valuation Ratios

The trailing PE ratio is 42.39 and the forward PE ratio is 32.29. Gland Pharma's PEG ratio is 1.79.

PE Ratio	42.39
Forward PE	32.29
PS Ratio	4.98
PB Ratio	3.33
P/TBV Ratio	3.48
P/FCF Ratio	35.23
P/OCF Ratio	n/a
PEG Ratio	1.79

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.01, with an EV/FCF ratio of 32.23.

EV / Earnings	38.79
EV / Sales	4.55
EV / EBITDA	21.01
EV / EBIT	30.05
EV / FCF	32.23

Financial Position

The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.04.

Current Ratio	4.16
Quick Ratio	2.80
Debt / Equity	0.04
Debt / EBITDA	0.26
Debt / FCF	0.39
Interest Coverage	39.58

Financial Efficiency

Return on equity (ROE) is 8.09% and return on invested capital (ROIC) is 6.28%.

Return on Equity (ROE)	8.09%
Return on Assets (ROA)	5.27%
Return on Capital (ROIC)	6.28%
Revenue Per Employee	13.97M
Profits Per Employee	1.64M
Employee Count	4,217
Asset Turnover	0.56
Inventory Turnover	1.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.71% in the last 52 weeks. The beta is 0.30, so Gland Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-4.71%
50-Day Moving Average	1,732.61
200-Day Moving Average	1,821.60
Relative Strength Index (RSI)	52.73
Average Volume (20 Days)	147,056

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gland Pharma had revenue of INR 58.90 billion and earned 6.92 billion in profits. Earnings per share was 41.98.

Revenue	58.90B
Gross Profit	31.87B
Operating Income	8.93B
Pretax Income	10.56B
Net Income	6.92B
EBITDA	12.57B
EBIT	8.93B
Earnings Per Share (EPS)	41.98

Full Income Statement

Balance Sheet

The company has 28.20 billion in cash and 3.27 billion in debt, giving a net cash position of 24.93 billion or 151.35 per share.

Cash & Cash Equivalents	28.20B
Total Debt	3.27B
Net Cash	24.93B
Net Cash Per Share	151.35
Equity (Book Value)	87.88B
Book Value Per Share	533.63
Working Capital	48.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.19 billion and capital expenditures -3.86 billion, giving a free cash flow of 8.32 billion.

Operating Cash Flow	12.19B
Capital Expenditures	-3.86B
Free Cash Flow	8.32B
FCF Per Share	50.51

Full Cash Flow Statement

Margins

Gross margin is 54.11%, with operating and profit margins of 15.16% and 11.74%.

Gross Margin	54.11%
Operating Margin	15.16%
Pretax Margin	17.94%
Profit Margin	11.74%
EBITDA Margin	21.35%
EBIT Margin	15.16%
FCF Margin	14.13%

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 1.12%.

Dividend Per Share	20.00
Dividend Yield	1.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	47.65%
Buyback Yield	-0.00%
Shareholder Yield	1.12%
Earnings Yield	2.36%
FCF Yield	2.84%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a